ReviewCurrent pharmaceutical biotechnology2026
Application of Traditional Chinese Medicines in Diabetes Mellitus: From Pathogenesis to Clinical Practice.
Review in Current pharmaceutical biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The recent research progress on traditional Chinese medicine application in Parkinson's disease: a review.Frontiers in aging neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Diabetes mellitus (DM) is a group of metabolic disorders characterised by insufficient insulin secretion and reduced insulin sensitivity in target tissues, leading to a range of metabolic abnormalities. DM has a profound global impact and exerts detrimental effects on patients' health. Traditional Chinese Medicines (TCMs), characterised by dialectical treatment principles and a holistic therapeutic philosophy, have been shown to play an important role in the management and alleviation of DM. In this review, we provide a concise overview of recent applications of TCMs in DM, summarise the underlying mechanisms, and discuss both the limitations of current practices and future prospects in this field. Numerous non-clinical and clinical studies have demonstrated the significant therapeutic advantages of TCMs in improving and alleviating DM. However, limitations persist, including variability among TCM formulations, the scarcity of high-quality randomised clinical trials, potential adverse effects and drug interactions, and challenges in standardisation. Establishing rigorous and scientifically sound quality standards, conducting larger-scale multicentre randomised controlled trials, and further elucidating the underlying mechanisms may offer effective solutions to these challenges and support the broader application of TCMs in DM management.
Indexed as
Identifiers
41664402What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.